Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine.
作者信息
Tsui Judith I, Stephens Daniel, Collins Brett, Denisiuk Eric, Hallgren Kevin A, Blalock Kendra L, Klein Jared W, Jack Helen E, Merrill Joseph O
出版信息
J Addict Med. 2023;17(4):491-492. doi: 10.1097/ADM.0000000000001129. Epub 2023 Jan 17.
Abstract
摘要
相似文献
1
Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine.对于开始使用丁丙诺啡的住院患者，甲基苯丙胺的同时使用与较低的门诊治疗衔接率相关。
J Addict Med. 2023;17(4):491-492. doi: 10.1097/ADM.0000000000001129. Epub 2023 Jan 17.
2
Reply to: "Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine".回复：“甲基苯丙胺的共同使用与开始使用丁丙诺啡的住院患者门诊治疗联系率较低有关”。
J Addict Med. 2023;17(4):492-493. doi: 10.1097/ADM.0000000000001130. Epub 2023 Jan 17.
3
Association between methamphetamine use and retention among patients with opioid use disorders treated with buprenorphine.美沙酮使用与丁丙诺啡治疗阿片类药物使用障碍患者保留的关联。
J Subst Abuse Treat. 2020 Feb;109:80-85. doi: 10.1016/j.jsat.2019.10.005. Epub 2019 Nov 18.
4
Outpatient Parenteral Antimicrobial Therapy Plus Buprenorphine for Opioid Use Disorder and Severe Injection-related Infections.门诊肠外抗菌治疗联合丁丙诺啡治疗阿片类药物使用障碍和严重注射相关感染。
Clin Infect Dis. 2020 Mar 3;70(6):1226-1229. doi: 10.1093/cid/ciz654.
5
Outpatient Rapid Microinduction of Sublingual Buprenorphine in 3 Days From Methadone for Opioid Use Disorder.门诊患者从美沙酮转换为舌下含服丁丙诺啡的3日快速微诱导用于阿片类物质使用障碍
Prim Care Companion CNS Disord. 2022 Dec 27;24(6):21cr03150. doi: 10.4088/PCC.21cr03150.
6
A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving.一项关于安非他酮和丁丙诺啡对减少甲基苯丙胺渴望效果的随机临床试验。
Trials. 2019 Jul 30;20(1):468. doi: 10.1186/s13063-019-3554-6.
7
Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial.比较丁丙诺啡和美沙酮在减少甲基苯丙胺渴求方面的效果：一项随机临床试验。
Trials. 2017 Jun 6;18(1):259. doi: 10.1186/s13063-017-2007-3.
8
The Effect of Buprenorphine on Methamphetamine Cravings.丁丙诺啡对甲基苯丙胺渴求的影响。
J Clin Psychopharmacol. 2015 Dec;35(6):724-7. doi: 10.1097/JCP.0000000000000408.
9
Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial.丁丙诺啡用于住院阿片类药物依赖患者的治疗：一项随机临床试验。
JAMA Intern Med. 2014 Aug;174(8):1369-76. doi: 10.1001/jamainternmed.2014.2556.
10
Methamphetamine dependence in methadone treatment services in Iran: the first literature review of a new health concern.伊朗美沙酮治疗服务中的甲基苯丙胺依赖：新健康问题的首次文献综述。
Asian J Psychiatr. 2018 Jan;31:49-55. doi: 10.1016/j.ajp.2018.01.001. Epub 2018 Jan 6.
引用本文的文献
1
Hospital readmissions and emergency department encounters among patients who initiate medications for opioid use disorder during hospitalization: Comparison of patients with and without co-occurring methamphetamine use.住院期间开始使用阿片类物质使用障碍药物治疗的患者的医院再入院情况及急诊科就诊情况：同时使用甲基苯丙胺与未同时使用甲基苯丙胺患者的比较。
J Subst Use Addict Treat. 2025 Oct;177:209765. doi: 10.1016/j.josat.2025.209765. Epub 2025 Jul 30.
2
mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with methamphetamine use and opioid use disorder.移动健康激励依从性加患者导航（MIAPP）：一项试点随机对照试验的方案，旨在改善甲基苯丙胺使用和阿片类药物使用障碍住院患者丁丙诺啡的联系和维持治疗。
Addict Sci Clin Pract. 2025 Jan 29;20(1):6. doi: 10.1186/s13722-025-00538-1.
3
Clinical progress note: Management of the hospitalized patient who uses methamphetamine.临床病程记录：使用甲基苯丙胺的住院患者的管理
J Hosp Med. 2025 Apr;20(4):380-384. doi: 10.1002/jhm.13521. Epub 2024 Oct 3.
4
Cross sectional analysis of an addiction consultation service, substance co-use patterns, and receipt of medications for opioid use disorder during hospitalization.横断面分析成瘾咨询服务、物质共病模式以及住院期间阿片类药物使用障碍药物治疗的获得情况。
J Subst Use Addict Treat. 2024 Dec;167:209505. doi: 10.1016/j.josat.2024.209505. Epub 2024 Sep 5.
5
Characteristics and co-morbidities associated with hospital discharges for opioid and methamphetamine co-use, United States 2016-2019.2016 - 2019年美国与阿片类药物和甲基苯丙胺共同使用导致出院相关的特征及合并症
Drug Alcohol Depend Rep. 2024 Feb 4;10:100219. doi: 10.1016/j.dadr.2024.100219. eCollection 2024 Mar.
6
Stimulant Co-use Is Associated With Patient-directed Discharges in Hospitalized Patients with Opioid Use and Injection Drug Use Related Infections.在患有阿片类药物使用及注射药物使用相关感染的住院患者中，兴奋剂联合使用与患者主导出院相关。
J Addict Med. 2023;17(6):746-747. doi: 10.1097/ADM.0000000000001226. Epub 2023 Sep 20.
本文引用的文献
1
The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review.冰毒/苯丙胺使用对阿片类药物使用障碍药物治疗的获得和结果的影响：系统评价。
Addict Sci Clin Pract. 2021 Oct 11;16(1):62. doi: 10.1186/s13722-021-00266-2.
2
Contingency management for the treatment of methamphetamine use disorder: A systematic review.应对甲基苯丙胺使用障碍的权变管理：系统评价。
Drug Alcohol Depend. 2020 Nov 1;216:108307. doi: 10.1016/j.drugalcdep.2020.108307. Epub 2020 Sep 21.
3
Predictors of Opioid and Alcohol Pharmacotherapy Initiation at Hospital Discharge Among Patients Seen by an Inpatient Addiction Consult Service.住院成瘾咨询服务患者出院时开始阿片类药物和酒精药物治疗的预测因素。
J Addict Med. 2020 Sep/Oct;14(5):415-422. doi: 10.1097/ADM.0000000000000611.
4
Association between methamphetamine use and retention among patients with opioid use disorders treated with buprenorphine.美沙酮使用与丁丙诺啡治疗阿片类药物使用障碍患者保留的关联。
J Subst Abuse Treat. 2020 Feb;109:80-85. doi: 10.1016/j.jsat.2019.10.005. Epub 2019 Nov 18.
Zotero 插件